A Prospective, Single-Arm, Multicenter Study to Investigate the Safety and Effectiveness of SAPIEN 3 Transcatheter Heart Valve Implantation in Patients With a Failing Aortic Bioprosthetic Valve

Trial ID or NCT#



not recruiting iconNOT RECRUITING


To assess the safety and effectiveness of the SAPIEN 3 (Edwards Lifesciences, Irvine, California) transcatheter heart valve in patients with a failing aortic bioprosthetic valve.


D. Craig Miller, MD
Alan C. Yeung, MD
Michael Fischbein, MD
William Fearon, MD
David Liang, MD
Rajesh Dash, MD
Anson Lee, MD